Pfizer: Number of Employees 2010-2024 | PFE
Interactive chart of Pfizer (PFE) annual worldwide employee count from 2010 to 2024.
- Pfizer total number of employees in 2023 was 88,000, a 6.02% increase from 2022.
- Pfizer total number of employees in 2022 was 83,000, a 5.06% increase from 2021.
- Pfizer total number of employees in 2021 was 79,000, a 0.64% increase from 2020.
- Pfizer total number of employees in 2020 was 78,500, a 11.1% decline from 2019.
| Pfizer Annual Employee Count |
| 2023 |
88,000 |
| 2022 |
83,000 |
| 2021 |
79,000 |
| 2020 |
78,500 |
| 2019 |
88,300 |
| 2018 |
92,400 |
| 2017 |
90,200 |
| 2016 |
96,500 |
| 2015 |
97,900 |
| 2014 |
78,300 |
| 2013 |
77,700 |
| 2012 |
91,500 |
| 2011 |
103,700 |
| 2010 |
110,600 |
| 2009 |
116,500 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$159.177B |
$58.496B |
|
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
|
